Growth Metrics

Fulgent Genetics (FLGT) Cash from Investing Activities (2016 - 2025)

Fulgent Genetics (FLGT) has disclosed Cash from Investing Activities for 11 consecutive years, with $11.2 million as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities rose 140.63% to $11.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $111.4 million through Dec 2025, up 290.86% year-over-year, with the annual reading at $111.4 million for FY2025, 290.86% up from the prior year.
  • Cash from Investing Activities hit $11.2 million in Q4 2025 for Fulgent Genetics, down from $19.1 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $53.4 million in Q2 2025 to a low of -$216.5 million in Q1 2021.
  • Historically, Cash from Investing Activities has averaged -$35.8 million across 5 years, with a median of -$204000.0 in 2022.
  • Biggest five-year swings in Cash from Investing Activities: crashed 6345.11% in 2021 and later surged 766.42% in 2024.
  • Year by year, Cash from Investing Activities stood at -$140.3 million in 2021, then skyrocketed by 33.98% to -$92.6 million in 2022, then surged by 126.21% to $24.3 million in 2023, then tumbled by 213.12% to -$27.5 million in 2024, then skyrocketed by 140.63% to $11.2 million in 2025.
  • Business Quant data shows Cash from Investing Activities for FLGT at $11.2 million in Q4 2025, $19.1 million in Q3 2025, and $53.4 million in Q2 2025.